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ABSTRACT
The aimed of the present study was to evaluate the liposomal formulation regarding its hydrophobicity. The evaluation 
studies were done based on the amphiphilic nature of the phospholipid liposomes. This paper highlights the importance 
of such type of lipid based carriers by encapsulation hydrophobic and hydrophilic drug models. Crystal violet and Nile 
red were used to represent hydrophilic and hydrophobic moieties before moving to pharmaceutical implications. The 
formulated liposomes were compared for their hydrophobicity using percent encapsulation efficiencies. The purpose of 
this formulation was to mimic the red blood cells. The average particle size of 120±25.1 and zeta potential of -10.2±1.4 
were in good agreement with reported characteristics of the red blood cells. Per cent encapsulation efficiency for crystal 
violet was more obvious with a value of 68.1 as compared to 36.5% for Nile red. The prepared liposomes were quite 
stable for a period of one month. Our findings reflect the fate of our system more suitable for hydrophilic drugs under 
the given set of formulation parameters.
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ABSTRAK
Matlamat kajian ini adalah untuk menilai penggubalan liposomal mengenai kehidrofobiannya. Kajian penilaian telah 
dijalankan berdasarkan sifat amfili daripada liposom fosfolipid. Kertas kerja ini membincangkan kepentingan apa-apa 
jenis penerbangan yang berpangkalan lipid oleh hidrofobi pengkapsulan dan model dadah hidrofili. Kristal ungu dan 
Nil merah telah digunakan untuk mewakili  moieti hidrofili dan hidrofobi sebelum berpindah ke implikasi  farmaseutik. 
Formulasi liposom dibandingkan untuk kehidrofobiannya menggunakan suatu kecekapan pengkapsulan peratus. Tujuan 
pembentukan ini adalah untuk meniru sel darah merah. Purata saiz zarah 120±25.1 dan potensi zeta daripada -10.2±1.4 
adalah sama dengan ciri yang dilaporkan untuk sel darah merah. Peratus kecekapan pengkapsulan untuk kristal ungu 
adalah lebih jelas dengan nilai sebanyak 68.1 berbanding 36.5% bagi Nil merah. Liposom yang disediakan agak stabil 
untuk tempoh satu bulan. Penemuan kami menunjukkan sistem kami lebih sesuai untuk dadah hidrofili  dengan parameter 
formulasi yang diberikan.
Kata kunci: Dadah kehidrofobiannya; kristal ungu; Nil merah; pembawa fosfolipid; peratus pengkapsulan
INTRODUCTION
Proper designs of drug delivery systems, its monitoring 
and evaluating strategies regarding specific targets have 
been very crucial in obtaining accurate stability and 
controlled drug release studies (Chen et al. 2014). In view 
of the stability and targeted delivery aspects, controlled 
average particle size (Karewicz et al. 2013), optimum 
lipid compositions (Mosca et al. 2011), drug loading 
strategies (Hou et al. 2013; Rossi et al. 2004), released 
kinetic studies (Hou et al. 2013; Millan et al. 2004) 
have played a significant role for the last few eras. This 
is done in order to enhance the collective inter-related 
effects of physical, chemical and biological stabilities of 
nano carriers especially liposomes (Ashraf et al. 2015; 
Krisenko et al. 2014; Zhu et al. 2013). Special attention 
has been given to liposomes as preferred drug delivery 
systems based on their amphiphilic nature (Cao et al. 
2010; Kastner et al. 2015). The inability to deliver drugs 
to the intended biological targets has long been a major 
obstacle in drug delivery systems. Liposomes are believed 
to offer minimum toxic side-effects by offering shielding 
effects for both hydrophilic and hydrophobic drugs of 
interest (Dyondi et al. 2015; Krasnici et al. 2003; Zhou 
et al. 2014). The liposomes are the vesicles having the 
ability to accommodate hydrophilic drugs in internal 
aqueous cores and the hydrophobic drugs in the lipid 
bilayer. The lipid bilayer protects the drug degradation on 
the way to targeted sites during circulation. Toxicity risks 
using liposomes are reduced which is a common practice 
for frequently used chemotherapeutics. Cisplatin and 
vincristine are among the examples which offer peripheral 
neurotoxicity and anthracyclines cardiotoxicity (Dimitriu 
et al. 2014; Rafiyath et al. 2012; Surhio et al. 2014). 
Liposomal delivery of chemotherapeutics like nausea and 
vomiting resulted in notably mild or even absence of any 
side effects which were generally associated with routine 
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chemotherapy treatments (Lee at al. 2010; Raymond et al. 
2011). In treatment of kaposi’s sarcoma (Raimundo et al. 
2013) and ovarian carcinoma patients (Kaye et al. 2012), 
DaunoXome and Doxil have been approved as liposomal-
based drugs in the present context (Dawidczyk et al. 2014; 
Szebeni et al. 2012). Ligands may also be accommodated 
for target based nanotechnology using liposomes. Being 
amphiphilic, both hydrophilic and hydrophobic drugs can 
be retained within the liposomes until they are reached the 
targeted side well in time.
 This study reports that the overall stability of 
our liposome formulation will not only be related to 
phospholipid moieties, special attention has been given 
to the encapsulation efficiencies of the liposomes. The 
formulation of liposomes was done in order to mimic the 
red blood cells (Hincha 2008; Merkel et al. 2011). The 
reported average particle size and zeta potential of the red 
blood cells is 80 to 150 nm and -9 to -15 mV, respectively 
(Chapanian et al. 2012; Huang et al. 2011). The study 
was conducted to check the hydrophobicity of the system 
using model dyes prior to any drug encapsulation. The 
encapsulation ability of the liposomes was compared 
for both hydrophilic and hydrophobic drugs. In order to 
determine the effect of lipid composition on the liposome 
stability and drug loading capacity, crystal violet and Nile 
red was used as model hydrophilic and hydrophobic drugs 
respectively (Cottenye et al. 2013; Manca et al. 2012). 
The chemical structures of the dyes are given in Figure 
1. We have used lecithin, Dipalmitolphosphatidylcholine 
(DPPC) (Elliott et al., 2005, Schaffran et al., 2010), 
Distearolyphosphatidylcholine (DSPC) (Lajunen et al. 
2015; Mfuh et al. 2011), phosphatidylserine (PS) (Dimitriu 
et al. 2014; Ran et al. 2015) and dicetyl phosphate (DCP) 
(Batool et al. 2015; El-Ridy et al. 2015; Sasaki et al. 2013) 
for liposomes formulation. The system developed was 
compared for its hydrophobicity using these model dyes 
with reference to its average particle size, zeta potential 
and per cent encapsulation efficacies.
MATERIALS AND METHODS
L-α-phosphatidylcholine from Soybean (CALBIOCHEM), 
Chloroform (Merck Sdn Bhd (Petaling Jaya, Selangor, 
Malaysia), Dipalmitolphosphatidylcholine (DPPC), 
Distearolyphosphatidylcholine (DSPC), phosphatidylserine 
(PS), dicetyl phosphate (DCP) and phosphate buffer saline 
(PBS) tablets (sigma-aldrich) were used. All the solutions 
and samples were prepared using deionized water 
(Barnstead DiamondTM RO unit, Barnstead International, 
USA). Further purification of chloroform was done by 
distillation followed by nitrogen gas purging in order to 
avoid oxidation of the lecithin.
PREPARATION OF LIPOSOME
Multilamellar liposomes were prepared by thin film 
hydration method described by Bangham in 1965. A 
definite quantity of lecithin was mixed with equal ratios 
of phospholipids and DCP using chloroform as solvent 
medium. The mixture was subjected to the rotary 
evaporator (50oC) followed by dispersion of resulted 
thin film with PBS dispersion medium (warmed at 50oC 
in water bath). The dispersion medium was 0.01M PBS 
at pH7.4. 
 Crystal violet and Nile red were encapsulated in the 
above formulated liposomes in a different way. Being 
hydrophobic, Nile red was dissolved in chloroform 
together with the lipid mixture. Crystal violet was 
dissolved in the phosphate buffer saline dispersion 
medium as per its hydrophilic nature. Thin film was then 
hydrated with the same medium later on. 
LIPOSOME SIZING 
Multilamellar liposomes were obtained as a result of thin 
film dispersion in PBS. These were then subjected to probe 
sonicator for proper sizing purpose. The sonicator was set 
at a total of 5 min process time. It was also further set at 
10 s pulse on and 15 s pulse off time for getting nano size 
liposomes. 
AVERAGE PARTICLE SIZE, ZETA POTENTIAL AND 
POLYDISPERSITY INDEX MEASUREMENT
The liposomes were analyzed for their size, zeta potential 
and polydispersity index using a Malvern NanoSeries 
ZetaSizer (Malvern, UK) at a constant temperature of 25oC.
(a) (b)
FIGURE 1. Chemical structures of crystal violet (a) and Nile red (b)
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TRANSMISSION ELECTRON MICROSCOPY
The prepared formulation was subjected to an energy 
Filtered TEM model LIBRA 120 (quipped with an Olympus 
SIS-iTEM, version 5) to study morphology of nanosized 
liposomes. The procedure followed involved the placement 
of one drop of formulation onto a carbon-coated copper 
grid. A filter paper was used to remove the excessive 
amount of formulation after 1 min. A negative stain, 2% 
phosphotungstic acid, was applied on the grid for only 1 
min. The excessive stain was also removed with the help 
of a filter paper. The grid was air dried initially and then 
was put in desiccator for five days before being examined 
under transmission electron microscope. 
CALIBRATION CURVES FOR CRYSTAL 
VIOLET AND NILE RED
The calibration curves for nile red and crystal violet were 
prepared by making different standard solutions from 
pure compounds. The solutions were subjected to the UV/
VIS spectrophotometer for absorbance measurements. The 
absorbance readings for crystal violet and Nile red were 
taken at λ max 589 and 537 nm, respectively.
ENCAPSULATION EFFICIENCY (% EE)
In order to determine the encapsulation efficiency of 
loaded liposomes, the loaded liposomes were subjected to 
ultrafiltration method. The liposomes were encapsulated 
with crystal violet and Nile red for determining the 
hydrophobicity of the liposome formulation under study. 
1 mg of each dye was loaded to compare the encapsulation 
efficiency using centrifugation process for 30 min at about 
9000 rpm (Vivaspin 6, Sartorius Stedim Biotech, Germany). 
The amount of encapsulated dyes was determined by 
taking supernatant of the centrifuged liposomes using 
Spectrophotometer (Cary 50 UV-VIS Spectrometer, Agilent 
Technologies, USA). The concentration of respective dyes 
in each sample was determined from standard calibration 
curves. The effect of centrifugation intensity was also 
noted. Per cent encapsulation efficiency was calculated 
using the following: 
  × 100    (1)
    
where WT is the total amount of dyes added; and WF is the 
amount of unloaded dyes.
STABILITY STUDIES
Stability of the liposomes encapsulating crystal violet and 
Nile red was determined by keeping them in dark at 37oC 
over a time period of one month. The stability studies were 
done with respect to average particle size, zeta potential 
and the polydispersity index using Malvern Zeta Sizer. 
RESULTS AND DISCUSSION
LIPOSOME DESIGN AND CHARACTERIZATION
The neutral head group present on the phosphotidylcholine 
molecules (PC) is known for stability of liposomes, 
however, negatively charged lipids also contribute towards 
this aspect according to previously reported studies. As 
a consequence, a combinatorial liposome approach has 
been followed since eras involving phospholipids with 
negatively charged head groups. The examples may 
include head groups such as phosphatidylglycerols (PG) 
to neutral phosphatidylcholine (PC) mixtures. Therefore, 
the present study also involves the negatively charged 
phospholipids as well. Liposomes were prepared from 
two different model dyes with varying hydrophobicity/
hydrophilicity. Water crystal violet has been found to have 
water solubility of 16 g/L at 25oC (Buckley et al. 2015; Dai 
et al. 2015). In contrast, water solubility values for Nile 
red have been reported as very slightly soluble in water 
(< 1 ug/mL) indicating its hydrophobic nature (Kurniasih 
et al. 2015; Ramireddy et al. 2015). The comparative 
systematic study of these two representative dyes allowed 
to investigate encapsulation efficiencies with reference to 
drug hydrophobicity. Liposome samples were prepared and 
characterized using Malvern Zeta Sizer. The samples were 
found to have the same size range of 120±26 nm, allowing 
a relatively valid stability comparison between the systems 
under study (Huang et al. 2011). The zeta potential and the 
polydispersity index were obtained as -9.6±2.1 and 0.5, 
respectively (Table 1). The focus was to mimic red blood 
cells, therefore, the attempts were made to attain a zeta 
potential of red blood cells i.e. -9 to -15 mV. 
MORPHOLOGY OF LIPOSOMES USING TEM
TEM images of the pure unencapsulated liposomes showed 
almost a spherical shape as shown in Figure 2. The small 
nanosized particles were in agreement with the Malvern 
zeta particle sizer, i.e. around 100 to 120 nm. TEM 
micrographs are shown in the figure with a single liposome 
in the inset with a scale bar of 100 nm. 
ENCAPSULATION EFFICIENCY 
The loaded liposomes were subjected to UV/Vis 
Spectrophotmeter analysis regarding encapsulation 
TABLE 1. Composition of the liposome for encapsulation of model dyes
Liposome composition (mg) Average particle size  (nm) Polydispersity index Zeta potential  (mV)
Lecithin: DPPC: DSPC: PS: DCP
(70:1:1:1:30)
120±25.1 0.416±0.01 -10.2±1.4
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efficiency measurements. The loaded liposomes were 
analyzed for encapsulation efficiency using standard 
calibration curves (Figure 3). The wavelengths used 
were 590 and 537 nm for crystal violet and Nile red, 
respectively. The supernatant from each sample was 
taken out at different speed of centrifuge machine like 
2500, 5000, 7500, 10000 and 12500 rpm. This was done 
in order to check the optimum speed for such liposomal 
suspensions. It was found that the absorbance values 
against each sample were increasing until almost a 
constant value for the last two speeds. The reason for 
this increase in absorbance value was attributed to the 
fact that low speeds of centrifuge were not sufficient to 
separate suspended liposomes from its fluid mediums 
(Khaskheli et al. 2015; Ming et al. 2015). It showed that 
the 10000 rpm may be used to centrifuge the liposomes 
with such lipid compositions. The encapsulation efficiency 
for both samples was measured with reference to the 
relevant standard calibration curves. The results showed 
that encapsulation efficiency for crystal violet was high in 
comparison with Nile red i.e 36 and 68.9% (Figure 4). This 
difference in the encapsulation led to a conclusion that the 
system developed for liposome formulation is well suited 
for the hydrophilic drugs more than the other. The Nile red 
is more likely to be entrapped in the lipophilic region of the 
liposomes owing to its very low water solubility (Wu et al. 
2015). On a contrary, the high water solubility of crystal 
violet let it be stored predominantly in the central aqueous 
compartments of the liposomes (Bennett et al. 2015; 
Papancea et al. 2015). This difference in potential storage 
locations render them sensitive where stability discussions 
are concerned as reported in previous literature. 
 The greater the phospholipid tail movements the 
greater are the expulsion of bilayer stored contents 
compared to the cargo stored in its cores. Therefore, 
literature also reports greater release of hydrophobic 
moieties reflective of the interplay between the physical 
FIGURE 2. Transmission electron microscopic image for the 
liposomes obtained at a scale of 0.5 μm (500 nm). The inset 
shows a single liposome at a scale of 100 nm
(a)
(b)
FIGURE 3. Standard calibration curves for crystal violet (a) and Nile red 
(b) using UV/VIS spectrophotometer
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properties of the cargo and phospholipid liposome 
compositions (Manca et al. 2012; Parente-Pereira et al. 
2014).
CONCLUSION
The present study has focused on the comparative 
approach of the liposome loading characteristics with 
model drug cargos as a function of average particle 
size, zeta potential, polydispersity index, stability 
and encapsulation efficiencies. Liposomes with major 
phospholipid contents were found to be comparatively 
stable over a time period of one month at 37oC. 
Hydrophilic drugs have been found to be well suited 
for the liposome formulation under study as compared 
to the hydrophobic drugs. Systematic correlations of 
delivery efficiencies for unique physical properties of 
liposomes can also account for a ‘tunable’ approach for 
drug transport and other applications. 
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